Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Skin Infections, Bacterial
Interventions
DRUG

SB-275833 ointment, 1%

Trial Locations (69)

1520

GSK Investigational Site, Daveyton

2113

GSK Investigational Site, Newtown

7460

GSK Investigational Site, Cape Town

7925

GSK Investigational Site, Cape Town

10435

GSK Investigational Site, Berlin

13500

GSK Investigational Site, Martigues

15831

GSK Investigational Site, Mahlow

24103

GSK Investigational Site, Kiel

24148

GSK Investigational Site, Kiel

24211

GSK Investigational Site, Preetz

24768

GSK Investigational Site, Rendsburg

31860

GSK Investigational Site, Labarth-Sur-Leze

40472

GSK Investigational Site, Düsseldorf

42103

GSK Investigational Site, Wuppertal

45190

GSK Investigational Site, Zapopan, Jalisco

45468

GSK Investigational Site, Mülheim

45879

GSK Investigational Site, Gelsenkirchen

47533

GSK Investigational Site, Kleve-Materborn

47798

GSK Investigational Site, Krefeld

48249

GSK Investigational Site, Duelmen

50674

GSK Investigational Site, Cologne

53177

GSK Investigational Site, Bonn

53604

GSK Investigational Site, Bad Honnef

57462

GSK Investigational Site, Olpe

59235

GSK Investigational Site, Bersée

59410

GSK Investigational Site, Anzin

59423

GSK Investigational Site, Unna

59690

GSK Investigational Site, Vieux-Condé

67547

GSK Investigational Site, Worms

75020

GSK Investigational Site, Paris

80801

GSK Investigational Site, Munich

81241

GSK Investigational Site, Munich

82205

GSK Investigational Site, Gilching

86179

GSK Investigational Site, Augsburg

95450

GSK Investigational Site, Seraincourt

560002

GSK Investigational Site, Bangalore

560034

GSK Investigational Site, Bangalore

R3A 1M3

GSK Investigational Site, Winnipeg

R3C 0N2

GSK Investigational Site, Winnipeg

A1E 2C2

GSK Investigational Site, St. John's

L6T 3J1

GSK Investigational Site, Brampton

P3E 6B4

GSK Investigational Site, Greater Sudbury

N2C 2N9

GSK Investigational Site, Kitchener

M9W 4L6

GSK Investigational Site, Toronto

Unknown

GSK Investigational Site, San José

04720

GSK Investigational Site, Döbeln

01097

GSK Investigational Site, Dresden

08468

GSK Investigational Site, Reichenbach

01762

GSK Investigational Site, Schmiedeberg

400 008

GSK Investigational Site, Mumbai

06780

GSK Investigational Site, Mexico City

3851 EX

GSK Investigational Site, Ermelo

1271 BB

GSK Investigational Site, Huizen

7581 BV

GSK Investigational Site, Losser

9581 AJ

GSK Investigational Site, Musselkanaal

9665 AR

GSK Investigational Site, Oude Pekela

6131 BK

GSK Investigational Site, Sittard

6027 RN

GSK Investigational Site, Soerendonk

7136 KH

GSK Investigational Site, Zieuwent

3331 LZ

GSK Investigational Site, Zwijndrecht

Lima 5

GSK Investigational Site, Breña

86-300

GSK Investigational Site, Grudziądz

40-027

GSK Investigational Site, Katowice

60-355

GSK Investigational Site, Poznan

50-368

GSK Investigational Site, Wroclaw

41-800

GSK Investigational Site, Zabrze

0084

GSK Investigational Site, Eloffsdal, Pretoria

GSK Investigational Site, Pretoia

0001

GSK Investigational Site, Pretoria

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY